Reversibly Modulating the Blood-Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles.

The blood-brain barrier (BBB) is highly selective and acts as the interface between the central nervous system and circulation. While the BBB is critical for maintaining brain homeostasis, it represents a formidable challenge for drug delivery. Here we synthesized gold nanoparticles (AuNPs) for targeting the tight junction specifically and demonstrated that transcranial picosecond laser stimulation of these AuNPs post intravenous injection increases the BBB permeability. The BBB permeability change can be graded by laser intensity, is entirely reversible, and involves increased paracellular diffusion. BBB modulation does not lead to significant disruption in the spontaneous vasomotion or the structure of the neurovascular unit. This strategy allows the entry of immunoglobulins and viral gene therapy vectors, as well as cargo-laden liposomes. We anticipate this nanotechnology to be useful for tissue regions that are accessible to light or fiberoptic application and to open new avenues for drug screening and therapeutic interventions in the central nervous system.

[1]  Hartwig Wolburg,et al.  Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects. , 2015, Seminars in cell & developmental biology.

[2]  Reactive astrocytes facilitate vascular repair and remodeling after stroke , 2021, Cell reports.

[3]  D. Kleinfeld,et al.  Entrainment of Arteriole Vasomotor Fluctuations by Neural Activity Is a Basis of Blood-Oxygenation-Level-Dependent “Resting-State” Connectivity , 2017, Neuron.

[4]  D. Ginty,et al.  Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis , 2017, Neuron.

[5]  Hiroshi Watanabe,et al.  Calcium signalling in endothelial cells. , 2000, Cardiovascular research.

[6]  K. Plate,et al.  Angiopoietin-2-induced blood–brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling , 2016, Acta Neuropathologica.

[7]  Jun Qian,et al.  Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist. , 2014, ACS nano.

[8]  David Fortin,et al.  Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood‐brain barrier for the treatment of patients with malignant brain tumors , 2000, Cancer.

[9]  David Kleinfeld,et al.  A polished and reinforced thinned-skull window for long-term imaging of the mouse brain. , 2012, Journal of visualized experiments : JoVE.

[10]  G. Terstappen,et al.  Strategies for delivering therapeutics across the blood–brain barrier , 2021, Nature Reviews Drug Discovery.

[11]  Reginald Birngruber,et al.  Inactivation of proteins by irradiation of gold nanoparticles with nano- and picosecond laser pulses , 2003, European Conference on Biomedical Optics.

[12]  W. Muller,et al.  Endothelial Cell Calcium Signaling During Barrier Function and Inflammation. , 2019, The American journal of pathology.

[13]  M. Frosch,et al.  Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain , 2019, Neuron.

[14]  J. Jokerst,et al.  Engineering Plasmonic Nanoparticles for Enhanced Photoacoustic Imaging. , 2020, ACS nano.

[15]  Xueyu Hu,et al.  Photobiomodulation and diffusing optical fiber on spinal cord’s impact on nerve cells from normal spinal cord tissue in piglets , 2021, Lasers in Medical Science.

[16]  Leland S. Hu,et al.  Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data , 2018, Neuro-oncology.

[17]  J. Götz,et al.  The blood-brain barrier: Physiology and strategies for drug delivery. , 2019, Advanced drug delivery reviews.

[18]  W. Pardridge,et al.  Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  K. Peremans,et al.  Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo , 2015, PloS one.

[20]  Elisabetta Dejana,et al.  Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. , 2004, Physiological reviews.

[21]  A. Idbaih,et al.  Blood-brain barrier disruption in humans using an implantable ultrasound device: quantification with MR images and correlation with local acoustic pressure. , 2020, Journal of neurosurgery.

[22]  H. Vinters,et al.  A quantitative analysis of blood-brain barrier ultrastructure in the aging human. , 1987, Microvascular research.

[23]  C. Mitchell,et al.  Intranasal Targeting of Hypothalamic PTP1B and TCPTP Reinstates Leptin and Insulin Sensitivity and Promotes Weight Loss in Obesity. , 2019, Cell reports.

[24]  Conglian Yang,et al.  Intracellularly generated immunological gold nanoparticles for combinatorial photothermal therapy and immunotherapy against tumor. , 2019, Nano letters.

[25]  B. Zlokovic,et al.  Blood-Brain Barrier: From Physiology to Disease and Back. , 2019, Physiological reviews.

[26]  A. Rezai,et al.  Noninvasive hippocampal blood−brain barrier opening in Alzheimer’s disease with focused ultrasound , 2020, Proceedings of the National Academy of Sciences.

[27]  K. Hynynen,et al.  Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. , 2004, Ultrasound in medicine & biology.

[28]  Xin-guo Jiang,et al.  Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release , 2021, Advanced science.

[29]  Zhenpeng Qin,et al.  Thermophysical and biological responses of gold nanoparticle laser heating. , 2012, Chemical Society reviews.

[30]  Vladimir P Torchilin,et al.  On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles , 2014, Nature Medicine.

[31]  E. Dejana,et al.  Transient Photo-Inactivation of Cell Membrane Protein Activity without Genetic Modification by Molecular Hyperthermia. , 2019, ACS nano.

[32]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[33]  Adrienne Minerick,et al.  Platinum-Decorated Gold Nanoparticles with Dual Functionalities for Ultrasensitive Colorimetric in Vitro Diagnostics. , 2017, Nano letters.

[34]  M. Bynoe,et al.  Adenosine Receptor Signaling Modulates Permeability of the Blood–Brain Barrier , 2011, The Journal of Neuroscience.

[35]  David R Busch,et al.  Laser safety in fiber-optic monitoring of spinal cord hemodynamics: a preclinical evaluation , 2018, Journal of biomedical optics.

[36]  Huile Gao,et al.  Progress and perspectives on targeting nanoparticles for brain drug delivery , 2016, Acta pharmaceutica Sinica. B.

[37]  S. Wilhelm,et al.  Elimination Pathways of Nanoparticles. , 2019, ACS nano.

[38]  Bernardo L. Sabatini,et al.  Caveolae in the CNS arterioles mediate neurovascular coupling , 2020, Nature.

[39]  R. Ransohoff,et al.  Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.

[40]  Maria O. Ogunyankin,et al.  Near-infrared Light Triggered-release in Deep Brain Regions Using Ultra-photosensitive Nanovesicles. , 2020, Angewandte Chemie.

[41]  E. Dejana,et al.  Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.

[42]  S. Gambhir,et al.  Miniature Gold Nanorods for Photoacoustic Molecular Imaging in the Second Near-Infrared Optical Window , 2019, Nature Nanotechnology.

[43]  D. Fortin,et al.  Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy , 2008, The AAPS Journal.

[44]  A. Asokan,et al.  Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[45]  Adam P. Silverman,et al.  Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys , 2020, Science Translational Medicine.

[46]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[47]  Ngan B. Doan,et al.  Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[48]  B. Barres,et al.  Reactive Astrocytes: Production, Function, and Therapeutic Potential. , 2017, Immunity.

[49]  P. Kang,et al.  Non-Arrhenius Reaction-Diffusion Kinetics for Protein Inactivation over a Large Temperature Range. , 2019, ACS nano.

[50]  Jessica C. Hsu,et al.  Recent advances in molecular imaging with gold nanoparticles. , 2019, Bioconjugate chemistry.